Spots Global Cancer Trial Database for bone marrow transplant complications
Every month we try and update this database with for bone marrow transplant complications cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant | NCT05709912 | Bone Marrow Tra... Hematologic Mal... | CARE Applicatio... Usual Care | 18 Years - | Massachusetts General Hospital | |
| Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma | NCT03200626 | Multiple Myelom... Bone Marrow Tra... | Autologous hema... | 18 Years - 70 Years | Medical College of Wisconsin | |
| Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy | NCT03394365 | Epstein-Barr Vi... Solid Organ Tra... Lymphoprolifera... Allogeneic Hema... Stem Cell Trans... | tabelecleucel | - | Atara Biotherapeutics | |
| Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey. | NCT05352789 | Haematological ... Bone Marrow Tra... Stem Cell Trans... Nutrition Aspec... Nutritional and... Exercise Interv... Prehabilitation | Non validated S... | 18 Years - | Nottingham University Hospitals NHS Trust | |
| High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD | NCT05895201 | Bone Marrow Tra... Acute Myeloid L... Acute Lymphobla... Myelodysplastic... Chronic Myelomo... | Sitagliptin Bortezomib Cyclophosphamid... | 18 Years - | Indiana University | |
| High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD | NCT05895201 | Bone Marrow Tra... Acute Myeloid L... Acute Lymphobla... Myelodysplastic... Chronic Myelomo... | Sitagliptin Bortezomib Cyclophosphamid... | 18 Years - | Indiana University | |
| Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy | NCT03394365 | Epstein-Barr Vi... Solid Organ Tra... Lymphoprolifera... Allogeneic Hema... Stem Cell Trans... | tabelecleucel | - | Atara Biotherapeutics | |
| Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey. | NCT05352789 | Haematological ... Bone Marrow Tra... Stem Cell Trans... Nutrition Aspec... Nutritional and... Exercise Interv... Prehabilitation | Non validated S... | 18 Years - | Nottingham University Hospitals NHS Trust | |
| Genetics in the Progression of Nephropathies | NCT06416761 | AKI CKD Ckd-Mbd CKD (Chronic Ki... ADPKD Hypertension Hematologic Mal... Bone Marrow Tra... | genetic polymor... | 18 Years - | Ospedale San Raffaele | |
| High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD | NCT05895201 | Bone Marrow Tra... Acute Myeloid L... Acute Lymphobla... Myelodysplastic... Chronic Myelomo... | Sitagliptin Bortezomib Cyclophosphamid... | 18 Years - | Indiana University | |
| Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002). | NCT04687982 | Bone Marrow Tra... Bone Marrow Tra... Graft Vs Host D... Infection Hematological M... | modified donor ... | 18 Years - | Istituto Clinico Humanitas | |
| Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors | NCT05611307 | Testicular Canc... Survivorship ASCVD Coronary Artery... Lipid Disorder Hypogonadism, M... Cisplatin Adver... Bone Marrow Tra... | Lipid profile Coronary artery... Hormone levels ... | 18 Years - 99 Years | Indiana University | |
| Genetics in the Progression of Nephropathies | NCT06416761 | AKI CKD Ckd-Mbd CKD (Chronic Ki... ADPKD Hypertension Hematologic Mal... Bone Marrow Tra... | genetic polymor... | 18 Years - | Ospedale San Raffaele |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
